Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized vs Intravenous Tranexamic Acid in FESS
NCT06725732Phase 1Recruiting
- Sponsor
- Assiut University
- Start
- Jan 2025
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of tranexamic acid (2 arms), sponsored by Assiut University. Primary endpoint: Modena Bleeding Score. Started Jan 2025; status: recruiting.
02
Drugs
tranexamic acid
Beyond the preview
Go deeper on NCT06725732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06725732.